SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-023302
Filing Date
2024-02-29
Accepted
2024-02-29 17:39:05
Documents
1
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6699
  Complete submission text file 0000950170-24-023302.txt   8117
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22 CORTLAND STREET, 16TH FLOOR NEW YORK NY 10007
Business Address
Murdock Hunter R. (Reporting) CIK: 0001934008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 24705450